Navigation Links
Spinal cord injury expert to be honored by research foundation
Date:10/18/2007

NEW BRUNSWICK/PISCATAWAY, N.J. Dr. Wise Young, the Richard H. Shindell Professor of Neuroscience at Rutgers University and founding director of Rutgers W.M. Keck Center for Collaborative Neuroscience, is receiving the Melvyn H. Motolinsky Research Foundations 2007 Distinguished Service Award.

The award will be presented at the foundations annual meeting Oct. 28 at 2 p.m. in the Conference Center of the Clinical Academic Building at University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School in New Brunswick.

Dr. Clifton R. Lacy, president of the Motolinsky Foundation, associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School and adjunct professor at Rutgers University Ernest Mario School of Pharmacy, said that Dr. Young was selected to receive the award because of his groundbreaking research in the treatment of spinal cord injury as well as his passionate support of stem cell research. We also recognize the compassion and caring he shows for individuals with spinal cord injury and their families, Lacy said.

Young is a world leader in the area of spinal cord injury and treatment. He is an outspoken advocate for stem cell research, a potential source of nerve cell regeneration therapies for damaged spinal cord tissue and other devastating conditions, such as Parkinsons and Alzheimers diseases. Young is taking a leadership position at home and abroad in gathering support for stem cell research and has carried his strong advocacy to patients and politicians in the state and into the halls of Congress.

Young practices what he calls "compassionate science," focusing on the needs of patients. He personally involves himself with people who have sustained these injuries and their families, holding regular open-house evenings at the Keck Center, where they are updated on the latest research findings and newest therapies.

At the Keck Center, Young assembled a team of researchers w
'/>"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. New device to help spinal cord injury cases walk
2. Useful device makes spinal surgery safer
3. New hope for spinal cord injury victims
4. Spinal Cord Patients Walk Again
5. Hope for Babies Born With Spinal Muscular Atrophy
6. New Findings Could Reduce The Extent Of Spinal Cord Injuries
7. Effective Diagnosis Of Spinal Cord Injuries
8. Acrolein may be the key to halting spinal cord damage
9. Treatment May Be Possible For Degenerative Brain And Spinal Cord Disease
10. Titanium Rib Found To Be Effective In Treating Spinal Deformities In Children
11. New Therapy Recommendations For Spinal Complications Of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...r an Injunction in Federal Court to Reclaim Overti...swire-USNewswire/ -- Registered nurses for Riversi... Medical Center, filed a Fair Labor Standards Act ...y to stop the county from violating federal law go... are seeking to represent all 867 registered nurse...
(Date:12/2/2008)...ire-USNewswire/ -- Are you unhappy with your smile... are available? , , The Pennsylvania Dental...metic options exist to improve your smile. Your de...tory to determine a suitable option to help restor...tic dental options. , , , , To...
(Date:12/2/2008)...edical Center ranks No. 1 nationwide for the speed...g balloon angioplasty, according to the National C... (Vocus) December 2, 2008 -- UCSF Medi...th which heart attack patients are treated using b...iovascular Data Registry (NCDR). Cardiac balloon ...
(Date:12/2/2008)...Breast-Specific Gamma Imaging (BSGI) has,been pro... the diagnosis of,invasive lobular carcinoma (ILC... a molecular breast imaging technique that can see...er very early stage cancers. When compared to,mam...g (MRI), BSGI has the,greatest sensitivity for de...
Breaking Medicine News(10 mins):Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...can make a difference. //Three-quarters of physici...a new study says they could be wrong. The new rese...ve at relieving back pain. Physicians often get f...pe of bed is best for their lower back pain. Few s...
...he Commonwealth's restaurants, taverns, and nightc...liquor-store sales as the House and Senate conclud.../ Working until nearly midnight, lawmakers also ap...to spur shoppers to spend more, thereby pumping up...
...t on a bill that would a prescription drug benefit...the politically popular entitlement program in its...lined up in our favor," House Speaker Dennis Haste...erence in the Capitol. "The time is upon us. It's ...
...arin in reducing stroke among people with an irreg...rug ximelagatran appears to be as effective as war...ople at high risk of stroke because of its blood t...he drawbacks of warfarin include an increased risk...
Other Medicine News:Health News:Senate assures ban on smoking 2Health News:Senate assures ban on smoking 3Health News:Senate assures ban on smoking 4Health News:House heads for Medicare drug vote, 2Health News:House heads for Medicare drug vote, 3
(Date:12/1/2008)...te Ltd today announced the initiation of a Phase 1...ctive JAK2 inhibitor, in leading medical centers i...yelofibrosis (CIMF). , , The trial is desi...1518 in patients with CIMF and is expected to enro...y will assess the safety profile and evaluate the ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3The impact of physical activity on weight bearing knee joint 2297 1The impact of physical activity on weight bearing knee joint 2297 2The impact of physical activity on weight bearing knee joint 2297 3Babies raised in bilingual homes learn new words differently than infants learning one language 2295 1Babies raised in bilingual homes learn new words differently than infants learning one language 2295 2Babies raised in bilingual homes learn new words differently than infants learning one language 2295 3Painful condition affecting kidney failure patients increases risk of death 2293 1Painful condition affecting kidney failure patients increases risk of death 2293 2Painful condition affecting kidney failure patients increases risk of death 2293 3APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 1APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 2
... WIRE)--Mar 26, 2007 - Inovio Biomedical Corp.,(AM...A vaccines and,a novel solid tumor ablation therap...s published a scientific paper prepared by,Inovio,...om a,non-human primate study of an investigational...omedical,s electroporation technology.,The paper, ...
...Outpatient Infusion Study in Patients with,Chronic...ican,College of Cardiology 56th Annual Scientific ... March 25, 2007,/PRNewswire/ -- Scios Inc. announc... study of nesiritide (NATRECOR(R)) showed a,neutra...eath and,cardiorenal hospitalization at 12 weeks, ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
...fely, the Hoefer GD 2000 uses a dry-heat vacuum me...through a heavy aluminum platen. , Dries acrylami...as thirty minutes., The heavy aluminum platen prov...bution under the gel., A clear silicone cover shee...
...ilizes a hot air drying device for polyacrylamide ...g frames at once. Gels are dried on a clear cellop...is recessed to provide a smooth, flat assembly sur...m includes a gel drying oven, 2 drying frames, 16 ...
The PRO6000 power supply is the latest edition to Thermo's power supply product offering. It sets new standards in proteomic and genomic electrophoresis. This product has unique features dedicated to
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus.
Medicine Products: